AAAAAA

   
Results: 1-25 | 26-50 | 51-70
Results: 1-25/70
LETHAL PULMONARY TOXICITY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES
Authors: LOHR F WENZ F SCHRAUBE P FLENTJE M HAAS R ZIERHUT D FEHRENTZ D HUNSTEIN W WANNENMACHER M
Citation: F. Lohr et al., LETHAL PULMONARY TOXICITY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES, Radiotherapy and oncology, 48(1), 1998, pp. 45-51
AMBULANT TREATMENT OF MULTIPLE-MYELOMA WI TH COMBINED VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE
Authors: EGERER G HEGENBART U SALWENDER H HAHN U HAAS R GOLDSCHMIDT H HUNSTEIN W
Citation: G. Egerer et al., AMBULANT TREATMENT OF MULTIPLE-MYELOMA WI TH COMBINED VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE, Deutsche Medizinische Wochenschrift, 122(17), 1997, pp. 531-535
TANDEM HIGH-DOSE THERAPY WITH IFOSFAMIDE, EPIRUBICIN, CARBOPLATIN ANDPERIPHERAL-BLOOD STEM-CELL SUPPORT IS AN EFFECTIVE ADJUVANT TREATMENTFOR HIGH-RISK PRIMARY BREAST-CANCER
Authors: HAAS R SCHMID H HAHN U HOHAUS S GOLDSCHMIDT H MUREA S KAUFMANN M WANNENMACHER M WALLWIENER D BASTERT G HUNSTEIN W
Citation: R. Haas et al., TANDEM HIGH-DOSE THERAPY WITH IFOSFAMIDE, EPIRUBICIN, CARBOPLATIN ANDPERIPHERAL-BLOOD STEM-CELL SUPPORT IS AN EFFECTIVE ADJUVANT TREATMENTFOR HIGH-RISK PRIMARY BREAST-CANCER, European journal of cancer, 33(3), 1997, pp. 372-378
CATARACT INCIDENCE AFTER TOTAL-BODY IRRADIATION
Authors: ZIERHUT D LOHR F SCHRAUBE P HUBER P HAAS R HUNSTEIN W WANNENMACHER M
Citation: D. Zierhut et al., CATARACT INCIDENCE AFTER TOTAL-BODY IRRADIATION, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 326-326
11Q DELETIONS IDENTIFY A NEW SUBSET OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CHARACTERIZED BY EXTENSIVE NODAL INVOLVEMENT AND INFERIOR PROGNOSIS
Authors: DOHNER H STILGENBAUER S JAMES MR BENNER A WEILGUNI T BENTZ M FISCHER K HUNSTEIN W LICHTER P
Citation: H. Dohner et al., 11Q DELETIONS IDENTIFY A NEW SUBSET OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CHARACTERIZED BY EXTENSIVE NODAL INVOLVEMENT AND INFERIOR PROGNOSIS, Blood, 89(7), 1997, pp. 2516-2522
MYELOABLATIVE THERAPY WITH BLOOD STEM-CELL TRANSPLANTATION IS EFFECTIVE IN MANTLE CELL LYMPHOMA
Authors: HAAS R BRITTINGER G MEUSERS P MUREA S GOLDSCHMIDT H WANNENMACHER M HUNSTEIN W
Citation: R. Haas et al., MYELOABLATIVE THERAPY WITH BLOOD STEM-CELL TRANSPLANTATION IS EFFECTIVE IN MANTLE CELL LYMPHOMA, Leukemia, 10(12), 1996, pp. 1975-1979
MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS WITH HIGH-DOSE CYCLOPHOSPHAMIDE (4 OR 7 G M(2)) AND GRANULOCYTE-COLONY-STIMULATING FACTORIN PATIENTS WITH MULTIPLE-MYELOMA/
Authors: GOLDSCHMIDT H HEGENBART U HAAS R HUNSTEIN W
Citation: H. Goldschmidt et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS WITH HIGH-DOSE CYCLOPHOSPHAMIDE (4 OR 7 G M(2)) AND GRANULOCYTE-COLONY-STIMULATING FACTORIN PATIENTS WITH MULTIPLE-MYELOMA/, Bone marrow transplantation, 17(5), 1996, pp. 691-697
HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: HAAS R MOOS M MOHLE R DOHNER H WITT B GOLDSCHMIDT H MUREA S FLENTJE M WANNENMACHER M HUNSTEIN W
Citation: R. Haas et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN LOW-GRADE NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 17(2), 1996, pp. 149-155
TREATMENT WITH VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE (VAD) ON OUTPATIENT BASIS IN MULTIPLE-MYELOMA
Authors: EGERER G HEGENBART U WALLMEIER M HAHN U HAAS R GOLDSCHMIDT H HUNSTEIN W
Citation: G. Egerer et al., TREATMENT WITH VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE (VAD) ON OUTPATIENT BASIS IN MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 3603-3603
HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION IN LOW-GRADE NON-HODGKINS-LYMPHOMAS (NHL)
Authors: HAAS R MUREA S MOOS M HOHAUS S GOLDSCHMIDT H HUNSTEIN W
Citation: R. Haas et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION IN LOW-GRADE NON-HODGKINS-LYMPHOMAS (NHL), Blood, 88(10), 1996, pp. 469-469
PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION AND AUTOGRAFTING FOLLOWING HIGH-DOSE THERAPY IN PATIENTS WITH MULTIPLE-MYELOMA (MM)
Authors: GOLDSCHMIDT H HAAS R HEGENBART U WALLMEIER M HOHAUS S WANNENMACHER M HUNSTEIN W
Citation: H. Goldschmidt et al., PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION AND AUTOGRAFTING FOLLOWING HIGH-DOSE THERAPY IN PATIENTS WITH MULTIPLE-MYELOMA (MM), Blood, 88(10), 1996, pp. 512-512
PATIENTS WITH ADVANCED MULTIPLE-MYELOMA (MM) SHOW A LOW NUMBER OF CIRCULATING B-CELLS IN PERIPHERAL-BLOOD WITH SIGNIFICANT REDUCTION AFTER VAD CHEMOTHERAPY
Authors: WALLMEIER M KALLMEYER C KIEL K MOOS M HEGENBART U HAAS R GOLDSCHMIDT H HUNSTEIN W
Citation: M. Wallmeier et al., PATIENTS WITH ADVANCED MULTIPLE-MYELOMA (MM) SHOW A LOW NUMBER OF CIRCULATING B-CELLS IN PERIPHERAL-BLOOD WITH SIGNIFICANT REDUCTION AFTER VAD CHEMOTHERAPY, Blood, 88(10), 1996, pp. 1551-1551
PROCEEDINGS OF THE SYMPOSIUM - 10 YEARS OF BLOOD STEM-CELL TRANSPLANTATION IN HEIDELBERG, GERMANY - JULY 7 AND 8, 1995
Authors: HAAS R HUNSTEIN W
Citation: R. Haas et W. Hunstein, PROCEEDINGS OF THE SYMPOSIUM - 10 YEARS OF BLOOD STEM-CELL TRANSPLANTATION IN HEIDELBERG, GERMANY - JULY 7 AND 8, 1995, Stem cells, 13, 1995, pp. 1-1
HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH NON-HODGKINS-LYMPHOMA
Authors: HAAS R MUREA S GOLDSCHMIDT H DOHNER H MOOS M WITT B EUGENHART R WANNENMACHER M HUNSTEIN W
Citation: R. Haas et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Stem cells, 13, 1995, pp. 28-35
SEQUENTIAL HIGH-DOSE TREATMENT WITH PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA
Authors: GOLDSCHMIDT H HEGENBART U MOOS M EUGENHART R WANNENMACHER M HAAS R HUNSTEIN W
Citation: H. Goldschmidt et al., SEQUENTIAL HIGH-DOSE TREATMENT WITH PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA, Stem cells, 13, 1995, pp. 36-41
DETECTION OF MINIMAL RESIDUAL DISEASE BY POLYMERASE CHAIN-REACTION INB-CELL MALIGNANCIES
Authors: MOOS M SCHULZ R CREMER F SUCKER C SCHMOHL D DOHNER H GOLDSCHMIDT H HAAS R HUNSTEIN W
Citation: M. Moos et al., DETECTION OF MINIMAL RESIDUAL DISEASE BY POLYMERASE CHAIN-REACTION INB-CELL MALIGNANCIES, Stem cells, 13, 1995, pp. 42-51
ADDITION OF DACARBAZINE OR CISPLATIN TO INTERFERON-ALPHA INTERLEUKIN-2 IN METASTATIC MELANOMA - TOXICITY AND IMMUNOLOGICAL EFFECTS
Authors: KEILHOLZ U SCHEIBENBOGEN C MOHLER T BROSSART P MACLACHLAN D GEUEKE AM JOCHIM A HUNSTEIN W
Citation: U. Keilholz et al., ADDITION OF DACARBAZINE OR CISPLATIN TO INTERFERON-ALPHA INTERLEUKIN-2 IN METASTATIC MELANOMA - TOXICITY AND IMMUNOLOGICAL EFFECTS, Melanoma research, 5(4), 1995, pp. 283-287
SERUM INTERLEUKIN-8 (IL-8) IS ELEVATED IN PATIENTS WITH METASTATIC MELANOMA AND CORRELATES WITH TUMOR LOAD
Authors: SCHEIBENBOGEN C MOHLER T HAEFELE J HUNSTEIN W KEILHOLZ U
Citation: C. Scheibenbogen et al., SERUM INTERLEUKIN-8 (IL-8) IS ELEVATED IN PATIENTS WITH METASTATIC MELANOMA AND CORRELATES WITH TUMOR LOAD, Melanoma research, 5(3), 1995, pp. 179-181
RESTRICTION OF T-CELL RECEPTOR V-BETA REPERTOIRE IN MELANOMA METASTASIS RESPONDING TO IMMUNOTHERAPY
Authors: MOHLER T WILLHAUCK M SCHEIBENBOGEN C PAWLITA M BLUDAU H BROSSART P HUNSTEIN W KEILHOLZ U
Citation: T. Mohler et al., RESTRICTION OF T-CELL RECEPTOR V-BETA REPERTOIRE IN MELANOMA METASTASIS RESPONDING TO IMMUNOTHERAPY, Melanoma research, 5(2), 1995, pp. 129-132
PREVENTION OF CATHETER-RELATED INFECTIONS BY SILVER-COATED CENTRAL VENOUS CATHETERS IN ONCOLOGICAL PATIENTS
Authors: GOLDSCHMIDT H HAHN U SALWENDER HJ HAAS R JANSEN B WOLBRING P RINCK M HUNSTEIN W
Citation: H. Goldschmidt et al., PREVENTION OF CATHETER-RELATED INFECTIONS BY SILVER-COATED CENTRAL VENOUS CATHETERS IN ONCOLOGICAL PATIENTS, Zentralblatt fur Bakteriologie, 283(2), 1995, pp. 215-223
LARGE-BORE CENTRAL VENOUS CATHETERS FOR THE COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS
Authors: HAHN U GOLDSCHMIDT H SALWENDER H HAAS R HUNSTEIN W
Citation: U. Hahn et al., LARGE-BORE CENTRAL VENOUS CATHETERS FOR THE COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS, Journal of clinical apheresis, 10(1), 1995, pp. 12-16
HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
Authors: GOLDSCHMIDT H HEGENBART U HAAS R HUNSTEIN W
Citation: H. Goldschmidt et al., HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA, Onkologie, 18(6), 1995, pp. 518-523
PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATIO N FOLLOWING MYELOABLATIVE THERAPY IN MULTIPLE-MYELOMA
Authors: GOLDSCHMIDT H HAAS R HUNSTEIN W
Citation: H. Goldschmidt et al., PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATIO N FOLLOWING MYELOABLATIVE THERAPY IN MULTIPLE-MYELOMA, Onkologie, 18(1), 1995, pp. 94-94
ACTIVATED CIRCULATING PLATELETS AND INCREASED PLATELET REACTIVITY IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)
Authors: SCHLENK R RUF A DOHNER H PATSCHEKE H HUNSTEIN W
Citation: R. Schlenk et al., ACTIVATED CIRCULATING PLATELETS AND INCREASED PLATELET REACTIVITY IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET), Thrombosis and haemostasis, 73(6), 1995, pp. 1002-1002
INTERFERON-ALPHA A THERAPY FOR HEPATITIS B-ASSOCIATED POLYARTERITIS-NODOSA
Authors: SONNTAG KC SCHWARZEYWILL M HUNSTEIN W
Citation: Kc. Sonntag et al., INTERFERON-ALPHA A THERAPY FOR HEPATITIS B-ASSOCIATED POLYARTERITIS-NODOSA, British journal of rheumatology, 34(5), 1995, pp. 486-487
Risultati: 1-25 | 26-50 | 51-70